GlassScriptPhysician profile
Justin D Stull
NPI 1861854747
$4,193.34
in general payments reported to CMS, 2019-2025
14 companies · $231 in 2025
The $231 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,209 · 2021: $1,152 · 2022: $419 · 2023: $1,002 · 2024: $180 · 2025: $231.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,250 · Travel and Lodging: $164.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,249.63 |
| Travel and Lodging | $163.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Liberty Surgical INC. | $1,082.00 | 2019 | |
| Synthes Gmbh | $540.81 | 2021 | |
| Nuvasive, INC. | $521.09 | 2022-2023 | Acp, Plif, Cohere |
| Stryker Corporation | $481.04 | 2021-2023 | Avs Anchor-L |
| Globus Medical, INC. | $402.93 | 2022-2025 | Excelsiusgps Robotic Navigation System, Xlif |
| Depuy Synthes Sales INC. | $399.94 | 2022-2025 | Symphony, Orthovisc, Monovisc |
| Medtronic, INC. | $373.83 | 2021-2023 | Intellis Adaptivestim, Synchromedii |
| Boston Scientific Corporation | $141.38 | 2024-2025 | Intracept Rf Probe, Intracept |
| Vertiflex, INC. | $126.74 | 2019 | |
| Zimvie INC. | $31.99 | 2024 | |
| Si-Bone, INC. | $28.77 | 2023 | |
| Sanara Medtech INC. | $25.36 | 2024 | Celleraterx |
| Vertex Pharmaceuticals Incorporated | $19.01 | 2025 | |
| Novus Surgical Consultants | $18.45 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Justin Stull listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.